









Markets
/
Stocks
/
nasdaq-srts
/

Sensus Healthcare Inc

SRTS

5.040USD

+0.200+4.13%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

82.86MMarket Cap

LossP/E TTM



Sensus Healthcare Inc

5.040

+0.200+4.13%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Sensus Healthcare Inc

Currency: USD Updated: 2026-02-06

Key Insights

Sensus Healthcare Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 75 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 7.33.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Sensus Healthcare Inc's Score

Industry at a Glance

Industry Ranking

75 / 205

Overall Ranking

207 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Sensus Healthcare Inc Highlights

StrengthsRisks

Sensus Healthcare, Inc. is a medical device company that is engaged in the development and delivery of non-invasive treatments for skin cancer and keloids. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.

Growing

The company is in a growing phase, with the latest annual income totaling USD 41.81M.

Undervalued

The company’s latest PE is -27.37, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 4.96M shares, decreasing 25.49% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 261.13K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of -0.03.

Analyst Rating

Based on 3 analysts

Buy

Current Rating

7.333

Target Price

+51.52%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Sensus Healthcare Inc is 7.28, ranking 94 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 6.88M, representing a year-over-year decrease of 22.12%, while its net profit experienced a year-over-year decrease of 177.61%.

Score

Industry at a Glance

Previous score

7.28

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

4.52

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.68

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.01

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.18

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Sensus Healthcare Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Sensus Healthcare Inc is 8.90, ranking 2 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -27.37, which is -701.47% below the recent high of 164.60 and -297.35% above the recent low of -108.74.

Score

Industry at a Glance

Previous score

8.90

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 75/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Sensus Healthcare Inc is 8.00, ranking 60 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 8.00, with a high of 8.00 and a low of 6.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 3 analysts

Buy

Current Rating

7.333

Target Price

+51.52%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Sensus Healthcare Inc

SRTS

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Sensus Healthcare Inc is 7.45, ranking 36 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 5.54 and the support level at 4.48, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.30

Change

0.15

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.098

Neutral

RSI(14)

57.052

Neutral

STOCH(KDJ)(9,3,3)

46.977

Neutral

ATR(14)

0.316

Low Volatility

CCI(14)

-15.178

Neutral

Williams %R

44.444

Buy

TRIX(12,20)

0.731

Sell

StochRSI(14)

45.977

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

5.012

Buy

MA10

5.061

Sell

MA20

5.012

Buy

MA50

4.390

Buy

MA100

3.937

Buy

MA200

4.155

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Sensus Healthcare Inc is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 30.17%, representing a quarter-over-quarter increase of 4.98%. The largest institutional shareholder is The Vanguard, holding a total of 728.92K shares, representing 4.44% of shares outstanding, with 1.38% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Solot (Edwin L)

1.25M

-18.78%

Sardano (Joseph C)

1.20M

+2.13%

The Vanguard Group, Inc.

Star Investors

728.92K

-1.50%

Pacific Ridge Capital Partners, LLC

573.39K

+26.09%

Dimensional Fund Advisors, L.P.

569.31K

-5.51%

Divisadero Street Capital Management, LP

452.90K

+39.49%

Driehaus Capital Management, LLC

288.73K

+22.26%

Florida State Board of Administration

264.78K

+39.60%

Renaissance Technologies LLC

Star Investors

261.13K

+4.40%

Acadian Asset Management LLC

229.12K

-39.29%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Sensus Healthcare Inc is 3.04, ranking 132 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.20. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.